We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva’s New Management Decides to Back Off Generic Lipitor Market
Teva’s New Management Decides to Back Off Generic Lipitor Market
May 29, 2012
A flood of Lipitor generics is expected to hit the market today, but Teva, the world’s largest generic-drug maker, has decided a better strategy is not to sell what was once the world’s best-selling drug — at least not yet.